{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-266722","form_type":"8-K","ticker":"URGN","cik":"0001668243","company_name":"UroGen Pharma Ltd.","filed_at":"2022-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.642560+00:00","generated_at":"2026-06-23T01:58:07.958602+00:00","sec_items":["2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"UroGen Pharma draws $25M second tranche from $100M BioPharma Credit facility","bullets":["$25M Tranche B Loan requested Oct 21, 2022; funding expected Dec 16, 2022.","Interest rate: 8.25% + 3-month LIBOR (floor 1.25%); matures March 2027.","Proceeds to be used for general corporate and working capital requirements.","Repayment in four equal quarterly payments starting after 17th quarter anniversary of Tranche A closing.","Prepayment premiums: 3% if before 3rd anniversary, 2% if 3-4 yrs, 1% if after 4 yrs; makewhole within 2 yrs."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-266722","json":"https://secwatch.observer/filing/0001193125-22-266722.json","markdown":"https://secwatch.observer/filing/0001193125-22-266722.md","text":"https://secwatch.observer/filing/0001193125-22-266722.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1668243/000119312522266722/0001193125-22-266722-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1668243/000119312522266722/d307901d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T01:58:07.958602+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}